Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 24.42B |
| Enterprise Value | 23.54B |
| P/E Ratio | 48.13 |
| PEG Ratio | 0.19 |
| Price/Sales Ratio | 15.44 |
| Price/Book Ratio | 13.96 |
| Enterprise/Revenue | 14.68 |
| Enterprise/EBITDA | 43.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.32 |
| Operating Margin | 0.32 |
| Return On Assets | 0.14 |
| Return On Equity | 0.39 |
| Revenue | 812.73M |
| Revenue/Share | 5.85 |
| Gross Profit | 732.85M |
| EBITDA | -191.04M |
| Net Income | -162.95M |
| Diluted EPS | -0.62 |
| Total Cash | 2.68B |
| Total Cash/Share | 10.14 |
| Total Debt | 1.04B |
| Total Debt/Equity | 0.61 |
| Current Ratio | 2.36 |
| Book Value Per Share | 6.47 |
| 52-Week Change | -20.53 |
| 52-Week High | 134.17 |
| 52-Week Low | 75.1 |
| Moving Average 50 Days | 98.51 |
| Moving Average 200 Days | 97.94 |
| Average Volume | 3.84M |
| Shares Outstanding | 264.71M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |